QPC Lasers, a company in the development and commercialization of high brightness, high power semiconductor lasers for the consumer, industrial, defense, and medical markets, announced that it has won a major contract to develop and deliver lasers to be used in rear projection televisions based on DLP and LCOS technologies.
NeuroMetrix, Inc., a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain, announced today that it has acquired substantially all of the assets of EyeTel Imaging, Inc. and has assumed certain specified liabilities in connection with the acquisition.
An analysis by the international LIGO (Laser Interferometer Gravitational-Wave Observatory) Scientific Collaboration has excluded one previously leading explanation for the origin of an intense gamma-ray burst that occurred last winter. Gamma-ray bursts are among the most violent and energetic events in the universe, and scientists have only recently begun to understand their origins.
Laser surgery to correct vision problems has been in use since the early 1990s. Photorefractive Keratotomy (PRK) is typically used to correct low to moderate myopia, while laser in-situ keratomileusis (LASIK) is preferred for high myopia corrections. Although over 18 million LASIK procedures have been performed worldwide, there is still some controversy regarding the maximum correction possible and efficacy with this technique.
The ultra-high data speeds possible on optical fibre networks will only come into their own when the fibres reach the last mile into everyone’s home. But that will require miniaturisation and integration of optical components on a scale not yet seen. European researchers may have some of the answers. Broadband access has transformed the economic potential of the internet.
When lasers were developed in the 1960s, they were a solution looking for a problem to solve. Since then, they have become an essential tool in industries as diverse as nanotechnology and biomedicine. A new generation of ultra-fast fibre lasers being developed in Europe is creating even more uses for the beams of high-intensity light, while lowering production and maintenance costs and increasing efficiency.
Photonic Products, the UK optoelectronics device manufacturer and laser diode specialist, has announced the introduction of two new, high power, infrared wavelength GaAlaS laser diodes from Opnext, Inc. The HL8337MG and the HL8338MG are ideal as light sources for industrial and medical sensor applications and as a light source for various other types of optical equipment such as distance meters, barcode scanners and high resolution CTP.
ROFIN-SINAR Technologies Inc., one of the world's leading developers and manufacturers of high-performance laser beam sources and laser- based solutions, today announced that it had signed a definitive agreement for the acquisition of Nufern as a wholly-owned subsidiary of RSTI, in a cash transaction. The transaction is expected to be closed in the first quarter of 2008. Further terms of the acquisition have not been disclosed.
Cleveland Laser Rehab, located at 27629 Chagrin Blvd, uses a non-invasive low level laser for meridian therapy. Meridian therapy is the use of a low level laser to treat acupuncture points on the surface of the ear (ear reflex points) and meridian points in other parts of the body. Meridian points are the invisible lines of energy which allow circulation between specific sets of acupuncture points.
Complex three-dimensional (3D) integrated circuits involving both optical and electronic elements are now easier to make, thanks to a “wafer bonding” technique developed by a European research consortium. With the right commercial backing, the new technology will help Europe stay competitive in communications and sensor technology.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.